Central and Peripheral Mechanisms of Corneal Pain

角膜疼痛的中枢和外周机制

基本信息

  • 批准号:
    10707313
  • 负责人:
  • 金额:
    $ 131.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

The cornea is the most densely innervated tissue in the body, and pain is the primary experience resulting from corneal stimulation. While physiological corneal pain (nociceptive pain) protects the eye from injury, inflammation and/or nerve damage can result in prolonged or chronic corneal pain. Corneal afferents represent a diverse population of neurons, with specialized properties related to maintaining ocular health. The full diversity of these neurons, and their responses to injury are unknown. The first set of experiments will determine the mRNA transcript signatures of mouse corneal neurons in the trigeminal ganglion (TG) and their transcriptional responses to corneal injury and compare with cell-type-specific transcriptional and epigenomic signatures of human TG neurons. Corneal afferents are known to project to two main regions in the spinal trigeminal nucleus (Vsp), each with distinct roles in nociception and maintaining corneal homeostasis. We have preliminary data demonstrating an additional projection to the lateral parabrachial nucleus (lPBN), a region critical in regulating complex motivational-affective responses to aversive stimuli. Its contribution to corneal pain is unknown. The second set of experiments will examine central processing of corneal input in the lPBN. We will determine the contribution of corneal->lPBN primary afferent projections to corneal nociceptive responses and the function of lPBN neurons in corneal nociceptive and chronic pain behaviors. Additional studies will perform single-nucleus transcriptome analysis to identify molecular profiles of corneal-activated brainstem neurons, followed by multiplex in situ hybridization to provide spatial resolution in regions that receive direct corneal afferent input. The cornea is also endowed with resident corneal leukocytes (RCLs) residing in close proximity to corneal nerves, suggesting the possibility of neuro-immune crosstalk in the cornea. However, current knowledge is limited on possible direct regulation of RCLs through corneal nerves, or the influence of RCLs on corneal nerve function. The third set of experiments will characterize the cell populations and molecular mechanisms involved in neuroimmune crosstalk resulting in peripheral nerve sensitization in the cornea. Corneal single cell mRNA transcript signatures associated in murine corneal pain models will be used to identify transcriptional changes that underly nociceptor sensitization. Crossing these immune cell transcripts with transcript profiles of corneal afferents will provide evidence for ligand-receptor pairs. In vitro studies will confirm the ability of the identified modulators to sensitize TG neurons, and the functional significance will be assessed using behavior and ex vivo electrophysiology. Employing a multidisciplinary approach, these experiments will provide a comprehensive analysis of cellular and molecular mechanisms of nociceptive and chronic corneal pain, leading to the identification novel pathways and treatments.
角膜是身体中神经支配最密集的组织,并且疼痛是由以下引起的主要体验: 角膜刺激虽然生理性角膜疼痛(伤害性疼痛)保护眼睛免受伤害, 炎症和/或神经损伤可导致长期或慢性角膜疼痛。角膜传入神经代表 一个多样化的神经元群体,具有与维持眼部健康相关的专门特性。充分 这些神经元的多样性及其对损伤的反应尚不清楚。第一组实验将 确定三叉神经节(TG)中小鼠角膜神经元的mRNA转录特征及其 角膜损伤的转录反应,并与细胞类型特异性转录和表观基因组比较 人类TG神经元的特征。已知角膜传入投射到脊髓中的两个主要区域 三叉神经核(VSP),每一个在伤害感受和维持角膜稳态中具有不同的作用。我们有 初步数据表明,额外的投影外侧臂旁核(lPBN),一个区域 在调节对厌恶刺激的复杂动机-情感反应中至关重要。其对角膜的贡献 疼痛是未知的。第二组实验将检查IPBN中角膜输入的中央处理。 我们将确定角膜->lPBN初级传入投射对角膜伤害性感受的贡献。 lPBN神经元在角膜伤害性和慢性痛行为中的反应和功能。额外 研究将进行单核转录组分析,以确定角膜激活的 脑干神经元,然后进行多重原位杂交,以提供空间分辨率的区域, 接受直接角膜传入输入。角膜也被赋予常驻角膜白细胞(RCL) 存在于角膜神经附近,这表明在角膜中存在神经免疫串扰的可能性。 角膜然而,目前对RCL可能通过角膜神经直接调节的了解有限,或者 RCL对角膜神经功能的影响。第三组实验将描述细胞的特征 参与神经免疫串扰的群体和分子机制导致周围神经 致敏作用。与小鼠角膜疼痛相关的角膜单细胞mRNA转录特征 模型将用于鉴定伤害感受器致敏的转录变化。穿越这些 免疫细胞转录本与角膜传入的转录本谱将为配体-受体结合提供证据。 对.体外研究将证实所鉴定的调节剂使TG神经元敏化的能力,以及所鉴定的调节剂对TG神经元敏化的能力。 将使用行为和离体电生理学来评估功能意义。采用 多学科的方法,这些实验将提供全面的分析细胞和分子 伤害性和慢性角膜疼痛的机制,导致识别新的途径, 治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pedram Hamrah其他文献

Pedram Hamrah的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pedram Hamrah', 18)}}的其他基金

The role of plasmacytoid dendritic cells in corneal immunity
浆细胞样树突状细胞在角膜免疫中的作用
  • 批准号:
    10640026
  • 财政年份:
    2023
  • 资助金额:
    $ 131.44万
  • 项目类别:
Central and Peripheral Mechanisms of Corneal Pain
角膜疼痛的中枢和外周机制
  • 批准号:
    10595408
  • 财政年份:
    2022
  • 资助金额:
    $ 131.44万
  • 项目类别:
Discovery of the Biomarker Signature for Neuropathic Corneal Pain
神经性角膜疼痛生物标志物特征的发现
  • 批准号:
    10617101
  • 财政年份:
    2019
  • 资助金额:
    $ 131.44万
  • 项目类别:
Mechanisms of Corneal Neuro-Immune Crosstalk
角膜神经免疫串扰的机制
  • 批准号:
    9913543
  • 财政年份:
    2018
  • 资助金额:
    $ 131.44万
  • 项目类别:
Mechanisms of Corneal Neuro-Immune Crosstalk
角膜神经免疫串扰的机制
  • 批准号:
    10393538
  • 财政年份:
    2018
  • 资助金额:
    $ 131.44万
  • 项目类别:
Mechanisms of Corneal Neuro-Immune Crosstalk
角膜神经免疫串扰的机制
  • 批准号:
    9789328
  • 财政年份:
    2018
  • 资助金额:
    $ 131.44万
  • 项目类别:
The role of plasmacytoid dendritic cells in ocular angiogenesis
浆细胞样树突状细胞在眼血管生成中的作用
  • 批准号:
    9318784
  • 财政年份:
    2017
  • 资助金额:
    $ 131.44万
  • 项目类别:
The role of plasmacytoid dendritic cells in ocular angiogenesis
浆细胞样树突状细胞在眼血管生成中的作用
  • 批准号:
    9893891
  • 财政年份:
    2017
  • 资助金额:
    $ 131.44万
  • 项目类别:
Role of plasmacytoid dendritic cells in corneal nerve health and regeneration
浆细胞样树突状细胞在角膜神经健康和再生中的作用
  • 批准号:
    9208776
  • 财政年份:
    2016
  • 资助金额:
    $ 131.44万
  • 项目类别:
The role of plasmacytoid dendritic cells in corneal immunity
浆细胞样树突状细胞在角膜免疫中的作用
  • 批准号:
    9329957
  • 财政年份:
    2016
  • 资助金额:
    $ 131.44万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 131.44万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了